During the past decade, AAS 3 Friuli Alto Medio Collin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AAS 3 Friuli Alto Medio Collin" are "Heart Failure" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "AAS 3 Friuli Alto Medio Collin" in a lesser frequency.

Most popular intervention types in "AAS 3 Friuli Alto Medio Collin" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Candesartan Cilexetil" (1 trials), "Candesartan matching placebo" (1 trials), "Neladenoson bialanate (BAY1067197)" (1 trials), "Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)" (1 trials) and "Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) 30/16mg matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "AAS 3 Friuli Alto Medio Collin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AAS 3 Friuli Alto Medio Collin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AAS 3 Friuli Alto Medio Collin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AAS 3 Friuli Alto Medio Collin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".